Inquiry Basket
Loading ......
The anti neutrophil autoantibody ELISA kit is a key laboratory tool designed for specific detection and quantification of autoantibodies against neutrophil components, mainly in the context of autoimmune vasculitis research. These kits utilize enzyme-linked immunosorbent assay (ELISA) technology to provide reliable quantitative data on autoimmune responses against key neutrophil antigens, such as myeloperoxidase (MPO) and protease 3 (PR3). Accurate measurement of these autoantibodies enables researchers to study disease mechanisms, monitor autoimmune activity, and evaluate therapeutic interventions for diseases such as ANCA associated vasculitis (AAV), including granulomatosis with polyangitis (GPA) and microscopic polyangitis. The anti-neutrophil autoantibody ELISA kit provides researchers with standardized methods for detecting and quantifying these key biomarkers, supporting basic research on disease pathogenesis and translational studies aimed at improving patient prognosis through better disease monitoring and management.
Figure 1. Antineutrophil Autoantibodies. (Jennette, J. Charles, 2014)
Antineutrophil cytoplasmic antibodies (ANCA) are a group of heterogeneous autoantibodies that primarily target antigens in neutrophil cytoplasmic granules and monocyte lysosomes. The two main antigen targets are myeloperoxidase (MPO) and protease 3 (PR3), which have different clinical associations and pathogenic significance. MPO-ANCA is most commonly seen in microscopic polyangitis (MPA) and eosinophilic granulomatosis with polyangitis (EGPA), while PR3-ANCA is closely associated with polyangitis granulomatosis (GPA). These autoantibodies are not only diagnostic markers, but are also believed to directly participate in the pathogenesis of diseases by activating the ability of activated neutrophils, leading to respiratory burst, degranulation, and endothelial damage. The relationship between ANCA associated vasculitis and cardiac involvement is an important research area.
Figure 2. Function of Neutrophil.
Anti neutrophil autoantibody markers are highly specific immunoglobulins that target the intracellular components of neutrophils and monocytes, serving as both diagnostic markers and potential mediators of vascular inflammation. These biomarkers vary in antigen specificity, clinical relevance, and research applications:
Anti-Myeloperoxidase (MPO) Antibodies
MPO-ANCA mainly belongs to the IgG class and is most commonly found in microscopic polyangitis (MPA) and eosinophilic granulomas with polyangitis, although it can also be detected in other autoimmune diseases.
Anti-Proteinase 3 (PR3) Antibodies
These autoantibodies target protease-3, a serine protease present in neutrophil sky blue granules with proteolytic, antibacterial, and inflammatory properties. PR3-ANCA has a strong correlation with granulomatosis.
Atypical ANCA Patterns
In addition to the classical cytoplasmic (c-ANCA) and perinuclear (p-ANCA) staining patterns specifically associated with PR3 and MPO, some patients also exhibit atypical ANCA patterns that may target other neutrophil antigens.
Neutrophil elastase is a serine protease that plays a role in neutrophil phagocytosis of microorganisms and mediating tissue inflammatory remodeling. Anti elastase antibodies are typically detected in systemic vasculitis and rheumatoid arthritis (RA).
Anti-neutrophil autoantibody ELISA kits serve diverse applications across basic research, preclinical studies, and therapeutic development:
Pathogenicity studies
These kits enable researchers to investigate the fundamental mechanisms of ANCA associated vasculitis, including epitope localization, antibody isotype conversion, and the correlation between autoantibody profiles and clinical manifestations.
Disease modeling and characterization
In experimental models such as MPO-ANCA induced vasculitis, ELISA kits enable researchers to quantify humoral responses to specific neutrophil antigens. This enables the characterization of autoimmune responses in different disease models and the evaluation of their correlation with clinical course and pathological outcomes.
Treatment monitoring and clinical trials
These ELISA kits provide objective endpoints for evaluating new therapies for autoimmune vasculitis. Researchers use a series of autoantibody measurements to evaluate treatment efficacy, identify target populations, and monitor the potential immunogenicity of biological therapies.
To ensure reliable results when using anti-neutrophil autoantibody ELISA kits, researchers should consider several technical aspects:
| Integration | Details |
 | Sample processing and storage: Proper collection and processing of samples are crucial for maintaining the stability of autoantibodies. Serum and plasma samples should be separated immediately after collection and stored at -20 ° C or -80 ° C for long-term preservation. Repeated freeze-thaw cycles should be avoided as they may affect the integrity of autoantibodies and lead to weakened detection signals. |
 | Testing optimization: Although commercial test kits provide standardized solutions, researchers may need to optimize certain parameters for specific applications. This includes determining the optimal sample dilution factor to ensure that the measured values fall within the linear range of the standard curve. When using new samples or experimental conditions, it is recommended to conduct preliminary titration experiments. |
 | Quality control implementation: Robust quality control measures should include testing and calibrating validators and control measures at each run, participating in external quality assurance plans where available, and regular instrument maintenance. Establishing laboratory specific reference ranges for specific research applications can improve data interpretation and reliability. |
Case Study 1: Mouse MPO ELISA Kit in Experimental Vasculitis Research
Background and Rationale: Myeloperoxidase (MPO) is a key target antigen for ANCA associated vasculitis, and MPO-ANCA plays a direct pathogenic role in disease development. Evaluated the performance of mouse MPO ELISA kit in detecting and quantifying MPO in experimental models of vasculitis, providing insights into disease mechanisms and potential therapeutic interventions.
Research Significance: The mouse MPO ELISA kit provides researchers with a robust and reliable method for quantifying MPO in experimental environments. Its application helps to study disease mechanisms, determine clinical relevance, and evaluate new treatment methods in the MPO-ANCA vasculitis model. The close association between MPO levels and disease outcomes emphasizes its value as a research tool for studying neutrophil activation and degranulation in autoimmune vasculitis.
Case Study 2: ANCA IgG ELISA Kit in Vasculitis Research
Background: IgG class anti neutrophil cytoplasmic antibodies are the main autoantibodies detected in ANCA associated vasculitis and have direct pathogenic significance. Evaluated the performance of ANCA IgG ELISA kit in detecting and quantifying total ANCA IgG antibodies in research applications, with a particular focus on its practicality in disease monitoring and characterization.
Research Significance:The ANCA IgG ELISA kit provides researchers with a standardized and quantitative method for detecting total ANCA IgG, which helps to study the humoral immune response in autoimmune vasculitis in detail. The correlation between ANCA IgG levels and disease activity supports its practicality in monitoring treatment response in research environments, while its powerful analytical performance ensures reliable results for research applications.
We collect and process clinical samples (serum/plasma) to eliminate hemolysis/hyperlipidemia and ensure compliance with pre analytical quality standards prior to testing.
We initialize the ELISA kit by preparing calibration samples constructed from standard curves and running low/high concentration quality control materials.
We add the processed sample to a pre coated microplate, incubate to form a sandwich complex, and perform sequential washing to remove non-specific binding.
We measured absorbance using a microplate reader, and calculated tumor marker concentrations using a validated regression model.
We cross validate the results based on the quality control scope, address potential interferences (such as hook effects), and generate clinically actionable reports.
The anti neutrophil autoantibody ELISA kit is an important tool for advancing research on autoimmune vasculitis and related inflammatory diseases. These complex immune assays provide researchers with the key ability to detect and quantify specific neutrophil targeted autoantibodies, with extremely high accuracy and reliability, significantly enhancing our understanding of the autoimmune pathogenesis affecting the vascular system. The detailed case studies of mouse MPO ELISA kit and ANCA IgG ELISA kit demonstrate the powerful application of this technology, which has performed well in experimental vasculitis research and human autoimmune disease research, respectively. The implementation of these standardized ELISA systems provides significant advantages for the entire research field.
MPO and PR3 antibodies are highly specific markers of ANCA associated vasculitis, with MPO-ANCA being more common in microscopic polyangitis (MPA) and eosinophilic granulomas with polyangitis, while PR3-ANCA is closely associated with granulomatosis with polyangitis (GPA). These autoantibodies not only aid in diagnosis, but may also directly participate in the pathogenesis of diseases through neutrophil activation and subsequent vascular inflammation.
Compared to the subjective and qualitative properties of IIF, ELISA systems provide objective, quantitative results and higher throughput. Although IIF provides valuable staining patterns (c-ANCA and p-ANCA), antigen-specific ELISA of MPO and PR3 has higher specificity for the diagnosis of ANCA related vasculitis. Many laboratories now use a combination of these two methods, or have transitioned to ELISA as their primary screening tool, with IIF reserved for suspected cases.
Most test kits have been validated and can be used with serum or plasma collected using standard techniques. Some tests can also accommodate other sample types, such as tissue culture supernatants or body fluids, for specialized research applications. Proper sample processing is crucial for maintaining the integrity of autoantibodies and obtaining reliable results.
Yes, quantitative autoantibody measurement can provide valuable information about treatment response in research environments. The decrease in MPO-ANCA or PR3-ANCA levels is associated with treatment response in some patients, although this relationship is not perfect, clinical relevance remains crucial. Continuous monitoring is most useful when consistent analysis methods are used over time.
Reference
Loading ......
